LATEST NEWS   At 6 pm, the ringgit rose to 4.0650/0690 versus the US dollar from Wednesday’s close of 4.0670/0715. | MPRC should lead the OGSE sector by building industry capacity, expanding market access and turning overseas opportunities into business outcomes — Akmal Nasrullah | Malaysia and Turkmenistan expected to sign a long-term hydrocarbon cooperation agreement on June 19 as part of efforts to strengthen the energy supply chain -- Akmal Nasrullah | Global supply crisis: Govt strengthening buffer stocks, to accelerate access to critical medicines if needed - Akmal Nasrullah | Global supply crisis: Labour forces rises to 17.33 million people, participation rate remains strong at 70.9 pct in April - Akmal Nasrullah | 
BUSINESS • 08/04/2026 05:35 PM

Meiji Pharma Asia Begins Operations In Singapore To Strengthen ASEAN Presence

KUALA LUMPUR, April 8 (Bernama) -- Meiji Seika Pharma Co Ltd has announced that its subsidiary, Meiji Pharma Asia Pte Ltd, commenced operations in Singapore on April 1, marking a strategic move to strengthen its presence in the ASEAN region.

In a statement, the company said the Singapore-based subsidiary will support the commercialisation, marketing and distribution of pharmaceuticals, including vaccines, across the region.

Meiji Seika Pharma aims to become “a leading company in Asia in the field of infectious diseases” under its “Meiji Group 2026 Vision”, leveraging nearly half a century of experience in manufacturing and marketing pharmaceuticals in Thailand and Indonesia.

Singapore will serve as a regional hub for the company’s business and commercial strategies, aimed at enhancing its influence and accelerating growth across ASEAN markets.

Established on Dec 10, 2025, Meiji Pharma Asia will focus on pharmaceuticals for infectious diseases, haematologic cancers and lifestyle-related diseases, with the aim of ensuring reliable supply and contributing to public health in the region.

-- BERNAMA

More News

Categories

Tags